DNA Link Inc (127120) — Capital Reinvestment Ratio
DNA Link Inc (127120) has a Capital Reinvestment Ratio of 0.52x as of December 2023, meaning it reinvests 1% of its operating cash flow (₩1.51 Billion) in capital expenditures (₩786.91 Million). Check 127120 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
DNA Link Inc Capital Reinvestment Ratio (2020–2022)
This chart tracks DNA Link Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see DNA Link Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for DNA Link Inc (2020–2022)
Year-by-year Capital Reinvestment Ratio for DNA Link Inc from 2020 to 2022. See how much free cash does DNA Link Inc generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 5.42x | ₩910.27 Million | ₩4.93 Billion | ▲ +319.1% |
| 2020 | 1.29x | ₩849.38 Million | ₩1.10 Billion | — |